Show simple item record

AuthorTan, Eva Maria Schiang Uhndc.contributor.author
Date of accession2016-03-14T15:21:50Zdc.date.accessioned
Available in OPARU since2016-03-14T15:21:50Zdc.date.available
Year of creation2006dc.date.created
AbstractThere are many known factors for the occurrence of Morbus Parkinson. It has been unknown how they interact. In the present study the influence of human dopamine transporter (hDAT) and alpha-synuclein mutations towards the toxicity of Parkinson-inducing toxins has been examined. Therefore we generated an in vitro Parkinson model. In a former study human embryonic kidney cells have been transfected with hDAT. These have been transfected with alpha-synuclein and its mutations. These cells were incubated with Parkinson-inducing toxins. The overall cell survival was measured with the MTT-assay. We were able to show that all alpha-synuclein isoforms aggravated a systemic mitochondrial-complex-I-inhibition through rotenone. But only the mutant alpha-synuclein were able to induce hDAT-dependant toxicity of very low concentrations of 1-Methyl-4-Phenylpyridinium ion (MPP+) in comparison to wild-type alpha-synuclein. We were able to show that there is hDAT-dependant interaction of mutant alpha-synuclein with Hydroxydopamine (6-OHDA) exposition in all cell lines. The inhibition of proteasomes through lactacystin did not have any influence on the MPP+ mediated toxicity in all cell lines. Put together our results implicate a neurotoxicity that is mediated via interaction of alpha-synuclein and hDAT. Oxidativ stress, alpha-synuclein and hDAT may cause in combination with protofibrill formation a mitochondrial dysfunction and may enhance the pathogenesis of idiopathic Parkinson syndrome. As our present results may show a new pathomechanism for a selective vulnerability of the dopaminergic cells towards 6-OHDA, our result can contribute to a better understanding in the aethiopathogenesis of selective neurodegeneration in idiopathic Parkinson syndrome. It remains unknown if the transport of toxic agents into the cell in the presence of alpha-synuclein isoforms in co-expression of hDAT is responsible for the increased vulnerability of the various neurotoxins.dc.description.abstract
Languagededc.language.iso
PublisherUniversität Ulmdc.publisher
LicenseStandard (Fassung vom 03.05.2003)dc.rights
Link to license texthttps://oparu.uni-ulm.de/xmlui/license_v1dc.rights.uri
Keyword6-Hydroxydopaminedc.subject
KeywordA30Pdc.subject
KeywordA53Tdc.subject
KeywordDopamintransporterdc.subject
KeywordHEK-293dc.subject
KeywordHEK-hDATdc.subject
Keywordmitochondriale Dysfunktiondc.subject
KeywordMPP+dc.subject
KeywordRotenonedc.subject
KeywordSynucleindc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
MeSHParkinson diseasedc.subject.mesh
TitleInteraktion zwischen Alpha-Synuclein und Dopamintransporter: Untersuchungen an heterologen Expressionsmodellendc.title
Resource typeDissertationdc.type
DOIhttp://dx.doi.org/10.18725/OPARU-1312dc.identifier.doi
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-vts-60686dc.identifier.urn
FacultyMedizinische Fakultätuulm.affiliationGeneral
Date of activation2007-11-23T08:43:42Zuulm.freischaltungVTS
Peer reviewneinuulm.peerReview
Shelfmark print versionZ: J-H 11.628 ; W: W-H 9.831uulm.shelfmark
DCMI TypeTextuulm.typeDCMI
VTS-ID6068uulm.vtsID
CategoryPublikationenuulm.category
University Bibliographyjauulm.unibibliographie


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record